Cargando…

Tenecteplase versus Alteplase for the Management of Acute Ischemic Stroke in a Low-income Country–Nepal: Cost, Efficacy, and Safety

Intravenous alteplase is the only approved treatment for acute ischemic stroke. Tenecteplase, a genetically engineered, mutant tissue plasminogen activator, is an alternative thrombolytic agent. The economic feasibility of stroke treatment has been a matter of huge debate and discussion thus far. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nepal, Gaurav, Kharel, Ghanshyam, Ahamad, Shaik Tanveer, Basnet, Babin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2018
Materias:	Emergency Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890961/ https://www.ncbi.nlm.nih.gov/pubmed/29651371 http://dx.doi.org/10.7759/cureus.2178

Ejemplares similares

Switching to Tenecteplase from Alteplase for Ischemic Stroke: Is it the Time for Universal Adoption?
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Status of prehospital delay and intravenous thrombolysis in the management of acute ischemic stroke in Nepal
por: Nepal, Gaurav, et al.
Publicado: (2019)

Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
por: Nguyen, Chi Phuong, et al.
Publicado: (2023)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review
por: Potla, Neha, et al.
Publicado: (2022)

Is Tenecteplase a Viable Alternative to Alteplase in the Treatment of Acute Ischemic Stroke?
por: Vaishnav, Anand Girish
Publicado: (2022)

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
por: Singh, Nishita, et al.
Publicado: (2023)

Biosimilar Tenecteplase Versus Alteplase in Acute Ischemic Stroke: A Real World Study
por: Mohan, Ayush, et al.
Publicado: (2023)

Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?
por: Mahmood, Ammad, et al.
Publicado: (2022)

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke
por: Logallo, Nicola, et al.
Publicado: (2014)

Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study
por: Dhar, Nikita, et al.
Publicado: (2022)

Role of female community health volunteers in ischemic stroke prevention, identification, referral and rehabilitation in Nepal
por: Basnet, Babin, et al.
Publicado: (2021)

Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials
por: Kobeissi, Hassan, et al.
Publicado: (2023)

Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Shen, Ziyi, et al.
Publicado: (2023)

Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
por: Dong, Yi, et al.
Publicado: (2021)

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials
por: Xu, Na, et al.
Publicado: (2018)

Real-world comparative safety and efficacy of tenecteplase versus alteplase in acute ischemic stroke patients with large vessel occlusion
por: Psychogios, Klearchos, et al.
Publicado: (2021)

Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study
por: Teivane, Agnete, et al.
Publicado: (2022)

Recanalization before Thrombectomy in Tenecteplase vs. Alteplase-Treated Drip-and-Ship Patients
por: Seners, Pierre, et al.
Publicado: (2019)

A Comparative Study of Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase Versus Tenecteplase
por: Ezzeldin, Mohamad, et al.
Publicado: (2023)

Low-cost alternatives for the management of acute ischemic stroke in low and middle-income countries
por: Nepal, Gaurav, et al.
Publicado: (2021)

Tenecteplase in Ischemic Stroke: Challenge and Opportunity
por: Li, Guangshuo, et al.
Publicado: (2022)

The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials
por: Abuelazm, Mohamed, et al.
Publicado: (2022)

Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design
por: Levin, Bruce, et al.
Publicado: (2011)

Emergency medical dispatcher training as a strategy to improve pre-hospital care in low- and middle-income countries: the case study of Nepal
por: Jacobson, Claire L., et al.
Publicado: (2021)

Different doses of tenecteplase vs. alteplase for acute ischemic stroke within 4.5 hours of symptom onset: a network meta-analysis of randomized controlled trials
por: Liang, Huo, et al.
Publicado: (2023)

The first reported case of Creutzfeldt‐Jakob disease from Nepal
por: Kharel, Himal, et al.
Publicado: (2019)

Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit—TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit
por: Bivard, Andrew, et al.
Publicado: (2022)

Using Tenecteplase for Acute Ischemic Stroke: What Is the Hold Up?
por: Zitek, Tony, et al.
Publicado: (2020)

A Case Report of Unilateral Orolingual Angioedema Secondary to Alteplase Administration
por: Harris, Dustin, et al.
Publicado: (2018)

Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials
por: Guillermin, Alexandre, et al.
Publicado: (2016)

The dangers of mass drug administration of albendazole in Nepal, a Neurocysticercosis-endemic region
por: Nepal, Gaurav, et al.
Publicado: (2020)

Effects of alteplase in the treatment of acute ischemic stroke
por: Yayan, Josef
Publicado: (2012)

Impact of poly-arginine peptides R18D and R18 on alteplase and tenecteplase thrombolysis in vitro, and neuroprotective stability to proteolysis
por: Meloni, Bruno P., et al.
Publicado: (2022)

Safety and efficacy of alteplase in the treatment of acute ischemic stroke
por: Micieli, Giuseppe, et al.
Publicado: (2009)

Thrombolysis for acute ischemic stroke by tenecteplase in the emergency department of a Moroccan hospital
por: Belkouch, Ahmed, et al.
Publicado: (2015)

Acute Ischemic Stroke Thrombolysis with Tenecteplase: An Institutional Experience from South India
por: Owais, Mohammed, et al.
Publicado: (2018)

Tenecteplase-induced Nonaneurysmal Subarachnoid Hemorrhage in a Patient with Acute Ischemic Stroke: A Case Report and Literature Review
por: Das, Biplab, et al.
Publicado: (2020)

Lifestyle Practices and Obesity in Nepalese Youth: A Cross-sectional Study
por: Nepal, Gaurav, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bnqdbcdgvljl7m2kq46snnoqta